Patents by Inventor LINDA S. KALTENBACH

LINDA S. KALTENBACH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
    Patent number: 11331291
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 17, 2022
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach, Peiying Yang
  • Method of and Improved Composition for Treating Triterpene-Responsive Conditions, Diseases or Disorders
    Publication number: 20210267920
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: March 8, 2021
    Publication date: September 2, 2021
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH, PEIYING YANG
  • Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
    Patent number: 10973785
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: April 13, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach
  • Method of and Improved Composition for Treating Triterpene-Responsive Conditions, Diseases or Disorders
    Publication number: 20210008017
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: June 8, 2020
    Publication date: January 14, 2021
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH
  • Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
    Patent number: 10722482
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: July 28, 2020
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach
  • Method of and Improved Composition for Treating Triterpene-Responsive Conditions, Diseases or Disorders
    Publication number: 20190076381
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH